D-Wave Quantum Stock Has Lost Two-Thirds of Its Value. Time to Buy?

Revenue rose to $25M in 2025 (+180% YoY) but net loss widened to $355M (vs $144M in prior year) and free cash flow was negative ~$76M; liquidity remains ~$884M. Shares outstanding increased ~27% last year, the stock is down roughly two-thirds from its high (but up ~35% since IPO), and it trades at an estimated P/S of ~180, implying extreme valuation. Conclusion: fundamentals do not justify a buy today — D-Wave is likely years from profitability and faces well‑funded competitors (Alphabet, IBM), leaving the equity speculative.

Analysis

D-Wave occupies a narrow but commercially oriented niche in quantum annealing that creates asymmetric second-order exposures outside the obvious quantum peers. Suppliers of precision cryogenics, RF control electronics and enterprise integration services stand to capture durable margin if on‑premise deployments scale, while cloud hyperscalers face deflationary pressure on their quantum-as-a-service pricing if customers prefer appliance-like solutions.

The biggest near-term risks are execution and narrative: missing a small number of enterprise milestones or a funding cadence misstep will compress an already sentiment-sensitive multiple quickly, whereas a handful of multi-year commercial contracts would create visible recurring revenue and markedly slow dilution. True technological obsolescence is a low‑probability but high‑impact tail risk — a gate-model or classical algorithm breakthrough that removes the annealing advantage would be a binary valuation event.

Tradeable asymmetries exist because market pricing embeds both binary upside and rapid downside from sentiment shifts. A hedged short using a defined‑risk put spread captures the downside while limiting funding drag, while a dollar‑neutral pair short QBTS / long IBM or GOOG isolates idiosyncratic quantum risk and lets broader AI/infra beta work in your favor. Meanwhile, long exposure to AI infrastructure (NVDA) serves as a convex hedge: if quantum fails to displace classical/accelerator routing for optimization workloads, GPU demand remains the default beneficiary.

Contrarian entry should be sized for a 12–36 month horizon: the consensus under-weights the value of sticky on‑premise contracts and IP that can produce annuity economics, but overprices near-term growth certainty. Positioning should therefore be asymmetric — limited-loss shorts or tight pairs now, with selective convex longs into measurable commercial verification events over the next 12 months.

Key Decisions for Investors

• Short QBTS via a defined‑risk put spread (3–6 month expiries): buy a ~25‑delta put and sell a ~10–12‑delta put to finance premium. Position size 1–2% of portfolio; max loss = premium paid, target payoff 2–4x if QBTS underperforms >40% within the window. Use a stop if spread mark‑to‑market loses >60% of premium.
• Pair trade: short QBTS / long IBM (dollar‑neutral) for 6–12 months to extract idiosyncratic quantum weakness while owning a diversified enterprise tech hedge. Size 2–4% net exposure; target relative outperformance of 30–60% (QBTS down or IBM up), cut pair if QBTS outperforms IBM by >20% in 3 months.
• Long NVDA LEAP or 9–12 month call spread (conservative): 2–3% portfolio. Rationale: captures AI infra upside if quantum adoption stalls and GPU/accelerator demand continues. Risk: NVDA pullback — cap by using call spreads; target asymmetric return 2–5x over 6–12 months.
• Event‑driven long on measurable commercial milestones: accumulate small (1%) long positions in GOOG or GOOGL on any announced enterprise quantum partnership or hardware certification (12–24 month horizon). These are tactical plays to capture durable platform beneficiaries if large customers standardize on gate‑model/cloud hybrids.